has mode of inheritance has causal genotype has causal molecular phenotype in guideline Autosomal Recessive Reduced Beta/Alpha Synthesis Ratio Thalassemia Constitutional Genetic Disorder Beta Thalassemia Suggest update to description Origa R. Beta-Thalassemia. 2000 Sep 28 [Updated 2018 Jan 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle 1993-2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1426/ http://en.wikipedia.org/wiki/Beta_thalassemia A hemoglobinopathy characterized by the reduced (beta plus) or absent (beta zero) synthesis of the beta globin chains of hemoglobin, resulting in variable outcomes ranging from severe anemia to clinically asymptomatic individuals. http://purl.obolibrary.org/obo/DOID_12241 Beta Type Thalassemia Suggest update to description in DOID. Include a "Dominant Beta-Thalassemia" sub-class? (see Orphanet) Beta-Thalassemia Beta Thalassemias DOID:12241 Beta-Thalassemias A. Cao and R. Galanello, "Beta Thalassemia", Genetics in Medicine, Vol. 12, No. 2, 2010, pp. 61 76. doi:10.1097/GIM.0b013e3181cd68ed Mediterranean Anemia Hemoglobin F Disease Beta Thalassemia Genotype Recommendations for the Management of Sickle Cell Disease in South Africa National Guideline for the Control and Management of Sickle Cell Disease A Parental Guide to Managing Sickle Cell Disease Standards for Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Disease: The Clinical Care Guidelines of the Sickle Cell Unit Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Sickle Cell Disease in Children, Standards and Guidelines for Clinic Care Evidence-Based Management of Sickle Cell Disease Management of Children with Sickle Cell Disease in Europe: Current Situation and Future Perspectives Reduced or Absent Hemoglobin A